Safety and efficacy of venglustat in GBA1-associated Parkinson's disease: an international, multicentre, double-blind, randomised, placebo-controlled, phase 2 trial

Giladi, Nir; Alcalay, Roy N.; Cutter, Gary; Gasser, Thomas; Gurevich, Tanya; Hoeglinger, Guenter U.; Marek, Kenneth; Pacchetti, Claudio; Schapira, Anthony H., V; Scherzer, Clemens R.; Simuni, Tanya; Minini, Pascal; Sardi, S. Pablo; Peterschmitt, M. Judith

Safety and efficacy of venglustat in GBA1-associated Parkinson's disease: an international, multicentre, double-blind, randomised, placebo-controlled, phase 2 trial

Autor(en):

Giladi, Nir; Alcalay, Roy N.; Cutter, Gary; Gasser, Thomas; Gurevich, Tanya; Hoeglinger, Guenter U.; Marek, Kenneth; Pacchetti, Claudio; Schapira, Anthony H., V; Scherzer, Clemens R.; Simuni, Tanya; Minini, Pascal; Sardi, S. Pablo; Peterschmitt, M. Judith

Tübinger Autor(en):

Gasser, Thomas

Erschienen in:

Lancet Neurology (2023), Bd. 22, H. 8, S. 661-671

Verlagsangabe:

New York : Elsevier Science Inc

Sprache:

Englisch

Referenz zum Volltext:

https://doi.org/10.1016/S1474-4422(23)00205-3

ISSN:

1474-4422